Rensun Pharmaceuticals Private Limited

Rensun Pharmaceuticals Private Limited - pharma in Mumabi, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2006PTC158896 Incorporated 16 January 2006 ROC Mumbai HQ Mumabi, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹60.92 Lakh
▲ 31% YoY
Net loss · FY 2025
₹2.99 Lakh
Net margin -4.9%
EBITDA · FY 2025
-₹21,490
EBITDA margin -0.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Rensun Pharmaceuticals Private Limited

Data last updated:

Rensun Pharmaceuticals Private Limited is a private limited company based in Mumabi, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2006PTC158896. Its GSTIN is 27AADCR2484B1ZK (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Bhushan Tiwari and Renu Sanjay Tiwari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 508 The Avenue Internationalairport Road Opp Hotel Leela Marol Andheri (E), Mumabi, Maharashtra, India – 400059.

As per the financials filed for FY 2025, the company reported a revenue of ₹60.92 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net loss of ₹2.99 Lakh (net margin -4.9%) and EBITDA of -₹21,490 (EBITDA margin -0.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 21% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rensun.in.

Company details

CIN U24230MH2006PTC158896
Registration Number 158896
Incorporation Date 16 January 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Rensun Pharmaceuticals Private Limited's registered office is in Mumabi, Maharashtra. Its website is rensun.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    508 The Avenue Internationalairport Road Opp Hotel Leela Marol Andheri (E), Mumabi, Maharashtra, India – 400059
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Rensun Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Rensun Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rensun Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Rensun Pharmaceuticals Private Limited, buy the company report.

Financials of Rensun Pharmaceuticals Private Limited

FY 2025 filings available

Rensun Pharmaceuticals Private Limited reported revenue of ₹60.92 Lakh (up 31% YoY) for FY 2025.

Revenue · FY 2025
₹60.92 Lakh ▲ 31%
Net loss · FY 2025
₹2.99 Lakh margin -4.9%
EBITDA · FY 2025
-₹21,490 margin -0.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 14%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 110%
3 years · compounded
▼ 27%
5 years · compounded
▼ 15%

Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 31% growth in the latest year. EBITDA fell 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹21,490
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.99 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-0.4%
Net Profit Margin-4.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rensun Pharmaceuticals Private Limited, buy the company report.

Board of directors of Rensun Pharmaceuticals Private Limited

Rensun Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay Bhushan TiwariDirector16 Jan 200620 Years 9 MonthsCurrent
Renu Sanjay TiwariDirector16 Jan 200620 Years 9 MonthsCurrent

Auditor

Rensun Pharmaceuticals Private Limited is audited by VAKILNA & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
VAKILNA & COFY 2017116767W

Shareholding

The shareholding of Rensun Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rensun Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rensun Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rensun Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AADCR2484B1ZKMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Rensun Pharmaceuticals Private Limited, buy the company report.

Recent activity

Rensun Pharmaceuticals Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Renu Sanjay Tiwari was appointed as Director on 16 Jan 2006.

AGM
Rensun Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rensun Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Renu Sanjay Tiwari was appointed as Director.
Appointed
Sanjay Bhushan Tiwari was appointed as Director.
Incorporation
16 Jan 2006
Rensun Pharmaceuticals Private Limited was registered on 16 Jan 2006 with Roc Mumbai I & aged 20 years 9 months as per MCA records.

Frequently asked questions

Rensun Pharmaceuticals is an active private limited company based in Mumabi, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2006 (20+ years old) and is registered under CIN U24230MH2006PTC158896.

Rensun Pharmaceuticals has 2 current directors:

The latest financial statements of Rensun Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Rensun Pharmaceuticals is 27AADCR2484B1ZK, registered in Maharashtra.

The CIN (Corporate Identification Number) of Rensun Pharmaceuticals is U24230MH2006PTC158896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rensun Pharmaceuticals was incorporated on 16 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

Renu Sanjay Tiwari was appointed as Director on 16 Jan 2006. Sanjay Bhushan Tiwari was appointed as Director on 16 Jan 2006.

Rensun Pharmaceuticals can be reached through the website rensun.in. Its registered office is in Mumabi, Maharashtra, India.

The registered office of Rensun Pharmaceuticals is at 508 The Avenue Internationalairport Road Opp Hotel Leela Marol Andheri E, Mumabi, Maharashtra, India – 400059.

Rensun Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.